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A B S T R A C T
This study presents the incidence of major nonmelanoma skin cancers (major NMSCs), other nonmelanoma skin
cancers (other NMSCs) and malignant melanoma (MM) in Croatia. The skin cancers recorded between 1 January 2003
and 31 December 2005 were retrospectively analyzed. Until 2003, the incidence of major NMSCs and other NMSCs was
not estimated in Croatia. Incident cases of NMSCs were identified by the use of a questionnaire distributed to dermatol-
ogy departments in Croatia and then collected at the University Department of Dermatology and Venereology, Zagreb
University Hospital Center, and from the records kept at the National Cancer Registry. Incident cases of MM were ex-
tracted from the National Cancer Registry. During the 3-year period, 9,479 cases of major NMSCs are recorded, 4,622
(49%) in male and 4,857 (51%) in female patients. The crude incidence rate was 72.1/100,000 for males and 70.3/100,000
for females. Basal cell carcinoma (BCC) was the most common major NMSC in both sexes. In the total number of major
NMSCs, there were 7,244 cases of BCC. Squamous cell carcinoma (SCC) was the second most common major NMSC.
There were 1,860 SCC cases. The crude incidence rate was 54.9/100,000 for BCC in males, 53.9/100,000 in females, and
14.6/100,000 for SCC in male and 13.4/100,000 in female patients. Other NMSCs were registered in 119 cases (53%male
and 47% female). The crude incidence rate was 0.9/100,000 for male and 0.8/100,000 for female patients. MM was regis-
tered in 1,427 cases (48%male and 52% female.) The crude incidence rate was 10.7/100,000 for males and females. These
results will serve as reference for studying the patterns of descriptive epidemiology of major NMSCs, other NMSCs and
MM in Croatia and Europe in the forthcoming years.
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Introduction
Nonmelanoma skin cancers (NMSCs) comprise the
most common group of skin cancers in the different parts
of the world1,2. In clinical practice major NMSCs refers to
squamous cell carcinoma (SCC), basal cell carcinoma
(BCC) and neoplasms with high malignant potential
such as Merkel cell carcinoma1,3,4. Major NMSCs and ma-
lignant melanoma (MM) incidence is increasing world-
wide5–7. Dermatologists have repeatedly criticized that
the public health importance of skin cancers is not appro-
priately reflected by the patient-based cancer incidence
rates of population-based cancer registries2. Until 2003,
the incidence of major NMSCs and other NMSCs in
Croatia was not reported. Upon the initiative of the Com-
mittee of Dermatology and Venereology, Ministry of
Health and Social Welfare, Republic of Croatia, since
January 2003, the incidence of major NMSCs and other
NMSCs has been monitored and studied at the Univer-
sity Department of Dermatology and Venereology, Zag-
reb University Hospital Center and National Cancer
Registry. Health institutions and private practice offices
are obliged to submit notification of all skin cancers to
the National Cancer Registry. In Croatia, malignant mel-
anoma (MM) has been registered since 1962 by the Na-
tional Cancer Registry8. The aim of the present study
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was to assess the incidence of major NMSCs, other NMSCs
and MM in Croatia during the 2003–2005 period.
Materials and Methods
Cases of major NMSCs, other NMSCs and MM re-
corded from January 1, 2003 to December 31, 2005 were
retrospectively analyzed. Data were derived from hospi-
tal discharge notification called »Onco type card« and
outpatient »Malignant neoplasm notification«, submit-
ted to the National Cancer Registry. The Croatian Na-
tional Cancer Registry at the Croatian National Institute
of Public Health was founded in 19598. Since 1994, it has
been a full member of the International Association of
Cancer Registries (IARC), and the data on cancer inci-
dence in Croatia have been included in the last three volu-
mes of Cancer Incidence in Five Continents publications5–7.
Under the Statistical Research Program promulgated by
the Parlament, health institutions and private health
practitioners are required to submit cancer notification
to the Registry. To improve data coverage, Committee of
Dermatology and Venereology of the Ministry of Health
and Social Welfare of Croatia designed the questionnaire
which contained information on major NMSCs and other
NMSCs diagnosed at major Dermatology departments in
Zagreb, Split, Rijeka and Osijek, and General Hospitals
in Zadar, Karlovac, Slavonska Po`ega, Slavonski Brod,
Vukovar and Dubrovnik. The questionnaire, »Onco type
card« and »Malignant neoplasm notification« contained
information on each patient (personal identification data,
sex, date of birth, place of residence, histopathologic type
of skin cancer and therapy) and information on the hos-
pital where patients were treated (name of the hospi-
tal/clinic and department, address, date of admittance
and date of discharge). The 38% of major and other
NMSCs were reported by the questionnaire and 62% by
the Registry. All incident cases of MM were extracted
from the National Cancer Registry8. Patients living abroad,
reports received in duplicate and cancer recurrences
were excluded. All skin cancers were verified by histo-
pathology. Keratoacanthoma and Bowen’s disease were
studied separately from invasive squamous cell carci-
noma (SCC). Data were encoded according to the In-
ternational Classification of Diseases Tenth Revision
(ICD-10), i.e. code C44 for basal cell carcinoma (BCC),
squamous cell carcinoma (SCC), basal-squamous cell car-
cinoma, Bowen disease, Merkel cell carcinoma, malig-
nant neoplasms of sebaceous and sweat glands and ex-
tramammary Paget disease, C46 for Kaposi sarcoma, C49
for sarcoma of connecting and soft tissues and unspeci-
fied sarcoma, C84 for lymphoma cutis and C43 for MM9.
Group of major NMSCs included BCC, SCC, basal-squa-
mous cell carcinoma, Bowen disease, Keratoacanthoma
and Merkel cell carcinoma. Paget disease, lymphoma
cutis, sarcoma cutis, porocarcinoma, pilomatrix carci-
noma, trichilemmal carcinoma, sebaceous gland carci-
noma and malignant fibrous histiocytoma were classified
as other NMSCs. Crude rate and age-specific incidence
rate were calculated on the basis of 2001 Croatian cen-
sus10. Age-standardized incidence rate of major NMSCs
and MM was calculated by the direct standardization
method, using the World Standard Population11. It was
not calculated for other NMSCs since it appeared in a
statistically irrelevant number.
Statistical analysis was done by use SPSS 13.0 soft-
ware.
Results
During the period from January 1, 2003 until Decem-
ber 31, 2005, a total of 9,479 major NMSCs were re-
ported, i.e. 4,622 (49%) in male and 4,857 (51%) in female
patients, male to female ratio 0.9 (Table 1). In the total
number of major NMSCs, the highest incidence was re-
corded for BCC (Table 1). There were 7,244 BCC cases,
i.e. 3,519 (76%) in male and 3,725 (77%) in female pa-
tients. SCC was the second most common major NMSC,
with the total of 1,860 SCC cases, 934 (20%) in males and
926 (19%) in females. The total of 119 other NMSCs were
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TABLE 1
MAJOR NONMELANOMA SKIN CANCERS AND MELANOMA IN CROATIA FROM 2003–2005
Total number Percentage Crude rate/100,000
Incidence
(World)/100,000
Males Females Males Females Males Females Males Females
Basal cell carcinoma 3,519 3,725 76* 77* 54.9 53.9 33.6 24.5
Squamous cell carcinoma 934 926 20* 19* 14.6 13.4 8.9 5.2
Basal-squamous cell carcinoma 25 38 0.5* 0.8* 0.4 0.5 0.2 0.2
Merkel cell carcinoma 6 2 0.1* 0.04* 0.09 0.02 0.05 0.005
Bowen disease 110 142 2* 3* 1.7 2.0 1.0 0.9
Keratoacanthoma 28 24 0.6* 0.5* 0.4 0.3 0.03 0.2
Total of major NMSCs 4,622 4,857 49* 51* 72.1 70.3 56.1 36.4
Melanoma 685 742 48† 52† 10.7 10.7 7.3 6.4
* Percentage of the total number of major NMSCs, † Percentage of the total number of MM
registered, i.e. 63 (53%) in male and 56 (47%) in female
patients, male to female ratio 1.1 (Table 2). Other NMSCs
that appeared in a statistically irrelevant number were
classified in the group of other skin cancers that included
porocarcinoma (3 cases in male and 0 female), pilomatrix
carcinoma (1 male and 1 female), trichilemmal carci-
noma (0 male and 2 female), malignant fibrous histio-
cytoma (1 male and 2 female) and sebaceous gland carci-
noma (2 male and 6 female) (Table 2). MM was recorded
in the total of 1,427 cases, i.e. 685 (48%) in male and 742
(52%) in female patients, male to female ratio 0.9 (Table
1). The age-specific incidence rate of BCC increases rap-
idly after the age of 60 in males and females, reaching the
peak at the age group 80–85 in both sexes (Figure 1). In
male and female patients, the age-specific incidence rate
of SCC has showed an increase after the age of 60, with
an abrupt rise and peak at the age of >80 (Figure 2). The
age-specific incidence rate of MM continuously increased
in all age groups in females, with a peak after the age of
80, and in males with a peak at the age group 55–59 and
at the age of >85 (Figure 3). Table 3 shows the age-stan-
dardized incidence rate adjusted to the World Standard
Population for skin cancers (C44) and MM (C43) in
Croatia and in different world areas.
Discussion
BCC and SCC are the most common cancers in hu-
mans which are usually not life threatening12. Despite
the low mortality, the economic costs from major NMSCs
are enormous13. Preston and Stern estimated that the
treatment of major NMSCs in the USA costs 500 million
dollars yearly14. A high number of these cancers were re-
corded during the 2003–2005 period in Croatia. However,
we believe that it is still underestimated due to variable
recording and reporting by the many different specialists
involved in the management of major NMSCs. The tim-
ing and periodicity of the ultraviolet light (UVL) expo-
sure appears to be important in its effect on subsequent
skin cancer risk2. The risk of BCC is increased by recre-
ational exposure to the sun during childhood and ado-
lescence15. Intense intermittent sun exposure is associ-
ated with a higher risk of BCC than as a similar degree of
continuous exposure15. SCC appears to be strongly re-
lated to cumulative sun exposure15. Exposure to ionizing
radiation, arsenic and metoxsalen and UV-A radiation
has also been linked to the development of BCC and
SCC15,16. Acute intermittent UVL exposure elevates the
risk of MM in the future17. The regular use of sunscreen
has been shown to inhibit the development of potential
precursors to invasive skin cancers such as actinic kera-
toses, Bowen disease and dysplastic nevi18–20. Croatia is
partly a Mediterranean country whose coast and islands
have more than 2,600 hours of sunshine per year21. In
the inland there are a lot of agricultural households22
which contributes to intensive periodical sun exposure of
the population. The data on occupational and recre-
ational exposure to the UVL and other risk factors for
skin cancers in Croatian population are not available.
Until now there was only one published article on the re-
gional differences of the BCC incidence among certain
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TABLE 2
OTHER NONMELANOMA SKIN CANCERS IN CROATIA FROM 2003–2005
Total number Percentage* Crude rate/100,000
Males Females Males Females Males Females
Paget disease (extramammary) 1 7 2 13 0.01 0.1
Mycosis fungoides 16 9 25 16 0.2 0.1
Lymphoma, unspecified 5 3 8 5 0.07 0.04
Kaposi sarcoma 15 13 24 23 0.2 0.2
Leiomyosarcoma 7 3 11 5 0.1 0.04
Dermatofibrosarcoma protuberans 4 3 6 5 0.06 0.04
Sarcoma, unspecified 8 7 13 13 0.1 0.1
†Other skin cancers 7 11 11 20 0.1 0.2
Total 63 56 53 47 0.9 0.8
* Percentage of the total number of other NMSCs, †Porocarcinoma, Pilomatrix carcinoma, Trichilemmal carcinoma, Sebaceous gland
carcinoma and Malignant fibrous histiocytoma
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Fig. 1. The age-specific incidence rate of basal cell carcinoma ac-
cording to sex (mean per year).
parts of Croatia23. The major NMSCs and MM incidence
is rising all over the world5–7. In Europe, a doubling of
MM rates every 10–20 years has been observed since
1970s24. The trend has stabilized in Northern European
countries, but rapidly increasing rates are still observed
in Southern and Eastern Europe24. MM incidence rates
increase with proximity to the Equator, however, in Eu-
rope, the highest incidence rates are observed in the
Northern Europe5–7. MM incidence in Croatia is lower
than in the neighboring Slovenia, but higher than in ar-
eas of more Southern latitude in some other Mediterra-
nean countries, such as Spain and Italy5–7. Due to much
lower coverage of incidence data worldwide5–7 the epide-
miology of major NMSCs has not been so extensively
studied. The latest edition of the Cancer Incidence in
Five Continents publication presents cancer incidence
data for the period from 1998 to 20027. The data on skin
cancers (C44) and MM (C43) incidence for selected regis-
tries are presented in Table 3. Of the member registries
included in the publication, Brazil (Goiania) had the
highest age-standardized incidence rate of NMSCs (C44)
(198.1/100,000 for males and 177.1/100,000 for females)7.
In Europe, the highest rates are observed in Switzerland,
Geneva (133.1/ 100.000 for males and 113.0/100,000 for
females)7. The age-standardized incidence rates for skin
cancers (C44) and MM (C43) in Croatia were higher than
in most of the Mediterranean countries. However, the
manifold differences incidence of NMSCs observed be-
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TABLE 3
THE AGE-STANDARDIZED INCIDENCE RATE ADJUSTED FOR THE WORLD STANDARD POPULATION FOR SKIN CANCERS (C44)
AND MELANOMA (C43) IN DIFFERENT WORLD AREAS
Male/C44 Female/C44 Male/C43 Female/C43
Switzerland, Geneva 133.3 113.0 18.5 19.0
Malta 72.2 39.4 5.5 5.1
Italy, Genoa Province 60.5 39.0 7.9 7.4
Italy Veneto Region 71.7 46.3 9.4 10.0
Italy, Varese Province 58.7 35.0 7.8 7.8
Croatia 55.3* 36.3* 6.9† 5.8†
Spain, Murcia 51.0 31.5 6.5 7.0
Slovenia 41.0 29.8 9.0 8.7
Italy, Naples 22.0 12.7 3.9 3.4
Austria 24.2 16.3 8.6 7.8
Serbia 24.1 17.6 4.0 3.8
Turkey, Antalya 19.8 15.4 1.3 1.0
Tunisia, Centre, Sousse 13.4 10.5 0.6 0.5
Algeria, Setif 7.7 4.5 0.2 0.4
Egypt, Gharbiah 6.8 2.5 0.3 0.3
Israel 3.4 3.0 11.2 9.5
Portugal, Porto 0.4 0.6 2.6 3.5
Source: Cancer Incidence in Five Continents, Vol IX, IARC (1998–2002), except C44 for Croatia
*The data of skin cancers (C44) in Croatia for the period from 2003–2005
†The data of melanoma for the period 1998–2002
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Fig. 3. The age-specific incidence rate of malignant melanoma
according to sex (mean per year).
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Fig. 2. The age-specific incidence rate of squamous cells carci-
noma according to sex (mean per year).
tween the areas of the similar latitude suggest severe
underreporting in some registration areas. Until this ef-
fort, the major NMSCs, as well as other NMSCs, such as
mycosis fungoides have been underreported in Croatia as
well, and further improvements in registration complete-
ness are expected. To date, Croatia has not reported data
on the incidence of major NMSCs to the IARC, the re-
sults presented will serve as reference data for the study
of descriptive epidemiology of skin cancers in Croatia
and Europe in the forthcoming years.
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S A @ E T A K
U radu je prikazana incidencija nemelanomskih tumora ko`e (»major NMSCs«), ostalih nemelanomskih tumora
ko`e (»other NMSC«) i malignog melanoma (MM) u Hrvatskoj. Slu~ajevi navedenih neoplazmi ko`e registrirani izme|u
1. sije~nja 2003. i 31. prosinca 2005. godine su retrospektivno analizirani. Do 2003. godine, incidencija nemelanomskih i
ostalih nemelanomskih tumora ko`e nije bila poznata. Slu~ajevi nemelanomskih i ostalih nemelanomskih tumora ko`e
registrirani su putem upitnika upu}enog dermatolo{kim ustanovama u Hrvatskoj i potom prikupljenih u Klinici za
dermatologiju i venerologiju Klini~kog bolni~kog centra Zagreb te putem prijava u Nacionalnom registru za rak. Slu-
~ajevi melanoma dobiveni su iz Nacionalnog registra za rak. Tijekom 3-godi{njeg perioda, registrirano je 9479 slu~ajeva
nemelanomskih tumora ko`e, 4622 (49%) u mu{karaca i 4857 (51%) u `ena. Stopa incidencije iznosila je 72,1/100.000 za
mu{karce i 70,3/100.000 za `ene. Bazocelularni karcinom (BCC) je bio naj~e{}i nemelanomski tumor u oba spola. Od
ukupnog broja nemelanomskih tumora, bilo je 7244 slu~ajeva BCC. Planocelularni karcinom (SCC) je drugi naj~e{}i
nemelanomski tumor. Registrirano je 1860 slu~ajeva SCC. Stopa incidencije iznosila je 54,9/100.000 za BCC u mu{ka-
raca, 53,9/100.000 za BCC u `ena te za SCC 14,6/100.000 u mu{karaca i 13,4/100.000 u `ena. Ostali nemelanomski
tumori registrirani su u 119 slu~ajeva (53% mu{karci i 47% `ene). Stopa incidencije bila je 0,9/100.000 za mu{karce i
0,8/100.000 za `ene. MM je registriran u 1427 slu~ajeva (48% mu{karci i 52% `ene.) Stopa incidencije bila je 10,7/
100.000 za mu{karce i `ene. Ovi rezultati poslu`it }e kao referentni podaci za budu}e deskriptivne epidemiolo{ke stu-
dije o nemelanomskim, ostalim nemelanomskim tumorima ko`e te melanomu u Hrvatskoj i Europi.
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